Gepostet in 2018.11.08. 00:05
NEW YORK, Nov. 7, 2018 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against Alnylam Pharmaceuticals, Inc. (“Alnylam” or the “Company”) (NASDAQ: ALNY) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and index under 18-cv-08845, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired Alnylam securities between February 22, 2017 and July 19, 2018, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue ...
Gepostet in der Kategorie Wirtschaft (Anzahl der ansichten:) 61
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Alnylam Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline – ALNY - Wirtschaft Nachrichten